Progyny, Inc. (PGNY) stock
PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 21/303% below fair value
$36.58+0.08 (+0.22%)
Close on Nov 12, 2026Market cap $2.81BP/E 33.6Yield –
Progyny ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Progyny's ebitda for the twelve months ending Sep 30, 2026 was $132.41M, up 46.6% year over year. For fiscal 2025 it was $90.23M, up 27.7% from the year before. The highest annual figure on record is $90.23M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.23M | +27.7% |
| FY2024 | Dec 31, 2024 | $70.63M | +9.6% |
| FY2023 | Dec 31, 2023 | $64.47M | +158.5% |
| FY2022 | Dec 31, 2022 | $24.94M | -25.9% |
| FY2021 | Dec 31, 2021 | $33.64M | +228.1% |
| FY2020 | Dec 31, 2020 | $10.25M | -13.2% |
| FY2019 | Dec 31, 2019 | $11.81M | – |
| FY2018 | Dec 31, 2018 | -$1.57M | – |
| FY2017 | Dec 31, 2017 | -$9.45M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $37.33M | +63.8% |
| Q2 FY2026 | Jun 30, 2026 | $41.63M | +62.8% |
| Q1 FY2026 | Mar 31, 2026 | $36.86M | +45.8% |
| Q4 FY2025 | Dec 31, 2025 | $16.59M | -0.4% |
| Q3 FY2025 | Sep 30, 2025 | $22.80M | +71.5% |
| Q2 FY2025 | Jun 30, 2025 | $25.56M | +19.2% |
| Q1 FY2025 | Mar 31, 2025 | $25.28M | +31.4% |
| Q4 FY2024 | Dec 31, 2024 | $16.66M | +15.4% |
| Q3 FY2024 | Sep 30, 2024 | $13.30M | -29.2% |
| Q2 FY2024 | Jun 30, 2024 | $21.44M | +36.5% |
| Q1 FY2024 | Mar 31, 2024 | $19.24M | +23.7% |
| Q4 FY2023 | Dec 31, 2023 | $14.43M | +284.7% |
| Q3 FY2023 | Sep 30, 2023 | $18.77M | +61.0% |
| Q2 FY2023 | Jun 30, 2023 | $15.71M | +70.3% |
| Q1 FY2023 | Mar 31, 2023 | $15.55M | +4982.4% |
| Q4 FY2022 | Dec 31, 2022 | $3.75M | +2831.3% |
| Q3 FY2022 | Sep 30, 2022 | $11.66M | +24.9% |
| Q2 FY2022 | Jun 30, 2022 | $9.22M | -22.8% |
| Q1 FY2022 | Mar 31, 2022 | $306.00K | -97.5% |
| Q4 FY2021 | Dec 31, 2021 | $128.00K | -92.1% |
| Q3 FY2021 | Sep 30, 2021 | $9.33M | +76.4% |
| Q2 FY2021 | Jun 30, 2021 | $11.95M | – |
| Q1 FY2021 | Mar 31, 2021 | $12.23M | +209.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.63M | -3.4% |
| Q3 FY2020 | Sep 30, 2020 | $5.29M | +46.8% |
| Q2 FY2020 | Jun 30, 2020 | -$612.00K | -121.1% |
| Q1 FY2020 | Mar 31, 2020 | $3.95M | +9.1% |
| Q4 FY2019 | Dec 31, 2019 | $1.68M | – |
| Q3 FY2019 | Sep 30, 2019 | $3.60M | – |
| Q2 FY2019 | Jun 30, 2019 | $2.90M | – |
| Q1 FY2019 | Mar 31, 2019 | $3.62M | – |
| Q4 FY2018 | Dec 31, 2018 | -$215.00K | – |
See a number that looks wrong?